Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma

NCT03901378 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Neuroendocrine Carcinoma
Large Cell Neuroendocrine Carcinoma of the Lung
High Grade Neuroendocrine Carcinoma, Any Site

Interventions

DRUG: Pembrolizumab

Sponsor

Ochsner Health System

Collaborators

[object Object]